DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Tosymra is a drug marketed by Upsher Smith Labs and is included in one NDA. There are seven patents protecting this drug.
This drug has sixty-one patent family members in nineteen countries.
The generic ingredient in TOSYMRA is sumatriptan. There are twenty-four drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the sumatriptan profile page.
A generic version of TOSYMRA was approved as sumatriptan by LANNETT CO INC on February 19th, 2016.
Summary for TOSYMRA
|Country||Patent Number||Estimated Expiration|
|Brazil||PI0923403||Get Started for $10|
|Japan||2012513412||Get Started for $10|
|World Intellectual Property Organization (WIPO)||2006025882||Get Started for $10|
|United Kingdom||202012086||Get Started for $10|
|Russian Federation||2018107419||Get Started for $10|
|Russian Federation||2011130526||Get Started for $10|
|European Patent Office||1789075||Get Started for $10|
|>Country||>Patent Number||>Estimated Expiration|